GL1X · GenesisL1 explorer

Research workbench

Structure of an anti-MCL1 scfv

Analyse Structure of an anti-MCL1 scfv in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6QB9
Type
protein
Length
473 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SCFV55
Pockets
4 · best druggability 0.49

Structure

x-ray diffraction · 2 distinct chains · 5% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASCFV55protein2375% helix, 49% strand—
XSCFV55protein2365% helix, 50% strand—

Ligands and binding sites

  • TLA · L(+)-tartaric acid · additive · 2 copies · chains X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11240.490.8024empty
21460.480.7828empty
3660.360.7713empty
4610.350.7712empty

Interfaces

1 interface between chains.

  • A–X · 50 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 6QB9 · Structure of an anti-Mcl1 scFv · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.